Answers are grounded in this paper and cite their sources.
Single-agent therapy and combination immune checkpoint inhibitor therapy are now approved for microsatellite-instability (MSI)–high colorectal cancer
No takes yet. Share an insight, caveat, or question.
David H. Ilson (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: